Peter J. Mogayzel

7.1k total citations · 3 hit papers
110 papers, 4.5k citations indexed

About

Peter J. Mogayzel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Peter J. Mogayzel has authored 110 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 20 papers in Epidemiology. Recurrent topics in Peter J. Mogayzel's work include Cystic Fibrosis Research Advances (67 papers), Tracheal and airway disorders (31 papers) and Neonatal Respiratory Health Research (31 papers). Peter J. Mogayzel is often cited by papers focused on Cystic Fibrosis Research Advances (67 papers), Tracheal and airway disorders (31 papers) and Neonatal Respiratory Health Research (31 papers). Peter J. Mogayzel collaborates with scholars based in United States, United Kingdom and Canada. Peter J. Mogayzel's co-authors include Bruce C. Marshall, Karen A. Robinson, Patrick A. Flume, Randall L. Rosenblatt, Christopher H. Goss, Leslie Hazle, Lynne M. Quittell, Robert J. Kuhn, Edward T. Naureckas and Lisa Lubsch and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Peter J. Mogayzel

105 papers receiving 4.4k citations

Hit Papers

Cystic Fibrosis Pulmonary Guidelines 2007 2026 2013 2019 2007 2009 2013 250 500 750

Peers

Peter J. Mogayzel
Harry Heijerman Netherlands
Robert W. Wilmott United States
Jeffrey S. Wagener United States
A.K. Webb United Kingdom
S.P. Conway United Kingdom
M.E. Hodson United Kingdom
Michael J. Rock United States
Nicole Mayer-Hamblett United States
Karen McCoy United States
Kevin W Southern United Kingdom
Harry Heijerman Netherlands
Peter J. Mogayzel
Citations per year, relative to Peter J. Mogayzel Peter J. Mogayzel (= 1×) peers Harry Heijerman

Countries citing papers authored by Peter J. Mogayzel

Since Specialization
Citations

This map shows the geographic impact of Peter J. Mogayzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Mogayzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Mogayzel more than expected).

Fields of papers citing papers by Peter J. Mogayzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Mogayzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Mogayzel. The network helps show where Peter J. Mogayzel may publish in the future.

Co-authorship network of co-authors of Peter J. Mogayzel

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Mogayzel. A scholar is included among the top collaborators of Peter J. Mogayzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Mogayzel. Peter J. Mogayzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Donaldson, Scott H., Timothy E. Corcoran, Joseph M. Pilewski, et al.. (2023). Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis. Journal of Cystic Fibrosis. 23(1). 155–160. 14 indexed citations
3.
Karnsakul, Wikrom, et al.. (2020). A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis. 19(4). 546–552. 17 indexed citations
4.
Bennett, William D., Kirby L. Zeman, Beth L. Laube, et al.. (2017). Homogeneity of Aerosol Deposition and Mucociliary Clearance are Improved Following Ivacaftor Treatment in Cystic Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(4). 204–211. 5 indexed citations
5.
Lechtzin, Noah, Nicole Mayer-Hamblett, Natalie E. West, et al.. (2017). Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results. American Journal of Respiratory and Critical Care Medicine. 196(9). 1144–1151. 86 indexed citations
6.
Mogayzel, Peter J., Edward T. Naureckas, Karen A. Robinson, et al.. (2014). Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection. Annals of the American Thoracic Society. 11(10). 1640–1650. 176 indexed citations
7.
Mogayzel, Peter J., Edward T. Naureckas, Karen A. Robinson, et al.. (2013). Cystic Fibrosis Pulmonary Guidelines. American Journal of Respiratory and Critical Care Medicine. 187(7). 680–689. 447 indexed citations breakdown →
8.
Mogayzel, Peter J. & Patrick A. Flume. (2011). Update in Cystic Fibrosis 2010. American Journal of Respiratory and Critical Care Medicine. 183(12). 1620–1624. 13 indexed citations
9.
Mogayzel, Peter J., Karen A. Robinson, & Patrick A. Flume. (2011). Totally Implantable Vascular Access Devices in Adult Patients for Cystic Fibrosis Management. American Journal of Respiratory and Critical Care Medicine. 183(1). 134–135.
10.
Green, Deanna, et al.. (2011). Treatment of Plastic Bronchitis by Orthotopic Heart Transplantation. Pediatric Cardiology. 32(8). 1193–1195. 16 indexed citations
11.
Paranjape, Shruti, et al.. (2011). Exercise improves lung function and habitual activity in children with cystic fibrosis. Journal of Cystic Fibrosis. 11(1). 18–23. 37 indexed citations
12.
Davis, Stephanie D., Margaret Rosenfeld, Gwendolyn S. Kerby, et al.. (2010). Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial Endpoints. American Journal of Respiratory and Critical Care Medicine. 182(11). 1387–1397. 77 indexed citations
13.
Collaco, Joseph M., Deanna Green, Garry R. Cutting, Kathleen Naughton, & Peter J. Mogayzel. (2010). Location and Duration of Treatment of Cystic Fibrosis Respiratory Exacerbations Do Not Affect Outcomes. American Journal of Respiratory and Critical Care Medicine. 182(9). 1137–1143. 79 indexed citations
14.
Mogayzel, Peter J. & Patrick A. Flume. (2010). Update in Cystic Fibrosis 2009. American Journal of Respiratory and Critical Care Medicine. 181(6). 539–544. 25 indexed citations
15.
Green, Deanna, Amanda Leonard, Shruti Paranjape, et al.. (2010). Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients. Journal of Cystic Fibrosis. 9(2). 143–149. 24 indexed citations
16.
Danziger‐Isakov, Lara, Sarah Worley, Marian G. Michaels, et al.. (2009). The Risk, Prevention, and Outcome of Cytomegalovirus After Pediatric Lung Transplantation. Transplantation. 87(10). 1541–1548. 47 indexed citations
17.
Flume, Patrick A., Peter J. Mogayzel, Karen A. Robinson, et al.. (2009). Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations. American Journal of Respiratory and Critical Care Medicine. 180(9). 802–808. 522 indexed citations breakdown →
18.
Flume, Patrick A., Brian O’Sullivan, Karen A. Robinson, et al.. (2007). Cystic Fibrosis Pulmonary Guidelines. American Journal of Respiratory and Critical Care Medicine. 176(10). 957–969. 765 indexed citations breakdown →
19.
Benden, Christian, Lara Danziger‐Isakov, T. Astor, et al.. (2007). Variability in immunization guidelines in children before and after lung transplantation. Pediatric Transplantation. 11(8). 882–887. 25 indexed citations
20.
Pollard, Harvey B., Ofer Eidelman, Catherine Jozwik, et al.. (2006). De Novo Biosynthetic Profiling of High Abundance Proteins in Cystic Fibrosis Lung Epithelial Cells. Molecular & Cellular Proteomics. 5(9). 1628–1637. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026